Published in Cancer Biol Ther on September 01, 2007
CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin Cancer Res (2009) 1.80
Expression of glutamate receptor subunits in human cancers. Histochem Cell Biol (2009) 1.31
Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice. Proc Natl Acad Sci U S A (2011) 1.12
Glutamate and its receptors in cancer. J Neural Transm (Vienna) (2014) 0.92
Immunomodulatory effects of domoic acid differ between in vivo and in vitro exposure in mice. Mar Drugs (2008) 0.84
Glutamate involvement in calcium-dependent migration of astrocytoma cells. Cancer Cell Int (2014) 0.78
A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol (2008) 7.35
Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A (2002) 4.18
Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci (2008) 4.04
Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol (2002) 3.30
Anesthesia-induced developmental neuroapoptosis. Does it happen in humans? Anesthesiology (2004) 3.22
Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome. Arthritis Rheum (2010) 2.50
Sedative and anticonvulsant drugs suppress postnatal neurogenesis. Ann Neurol (2008) 2.46
Metabolic regulation by the mitochondrial phosphatase PTPMT1 is required for hematopoietic stem cell differentiation. Cell Stem Cell (2013) 2.12
Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci (2003) 2.01
Ethanol-induced apoptotic neurodegeneration in the developing C57BL/6 mouse brain. Brain Res Dev Brain Res (2002) 1.89
Do pediatric drugs cause developing neurons to commit suicide? Trends Pharmacol Sci (2004) 1.67
Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol (2005) 1.51
Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol (2004) 1.49
Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure. Pediatr Crit Care Med (2011) 1.43
Suppression of the intrinsic apoptosis pathway by synaptic activity. J Neurosci (2010) 1.40
Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiol Dis (2008) 1.39
Levetiracetam: safety and efficacy in neonatal seizures. Eur J Paediatr Neurol (2010) 1.33
Expression of glutamate receptor subunits in human cancers. Histochem Cell Biol (2009) 1.31
NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth. Proc Natl Acad Sci U S A (2005) 1.30
Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain. Neurobiol Dis (2004) 1.30
Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol (2007) 1.26
Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity. Neurobiol Dis (2004) 1.23
Linking of sensor molecules with amino groups to amino-functionalized AFM tips. Bioconjug Chem (2011) 1.21
Oxygen causes cell death in the developing brain. Neurobiol Dis (2004) 1.18
Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue. J Neurosci (2004) 1.15
Anticancer agents are potent neurotoxins in vitro and in vivo. Ann Neurol (2004) 1.13
Neurodegeneration in newborn rats following propofol and sevoflurane anesthesia. Neurotox Res (2009) 1.11
Voltage-activated proton currents in human lymphocytes. J Physiol (2002) 1.10
In vivo detection limits of magnetically labeled embryonic stem cells in the rat brain using high-field (17.6 T) magnetic resonance imaging. Neuroimage (2004) 1.10
The enigma of fetal alcohol neurotoxicity. Ann Med (2002) 1.08
Brief alteration of NMDA or GABAA receptor-mediated neurotransmission has long term effects on the developing cerebral cortex. Mol Cell Proteomics (2008) 1.07
Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit. Proc Natl Acad Sci U S A (2005) 1.06
Antiepileptic drugs and brain development. Epilepsy Res (2009) 1.04
The role of matrix metalloproteinases in infant traumatic brain injury. Neurobiol Dis (2006) 1.03
Multiple sclerosis and glutamate. Ann N Y Acad Sci (2003) 1.03
CDK5RAP2 expression during murine and human brain development correlates with pathology in primary autosomal recessive microcephaly. Cereb Cortex (2012) 1.03
Origin of membrane dipole potential: contribution of the phospholipid fatty acid chains. Chem Phys Lipids (2002) 1.02
Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells. Naunyn Schmiedebergs Arch Pharmacol (2006) 1.01
Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine. Eur Respir J (2012) 1.01
RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo. Neuro Oncol (2011) 0.99
Glutamate receptors in pediatric tumors of the central nervous system. Cancer Biol Ther (2010) 0.98
FGF23 promotes renal calcium reabsorption through the TRPV5 channel. EMBO J (2014) 0.97
Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells. Scand J Gastroenterol (2011) 0.97
Silencing of selected glutamate receptor subunits modulates cancer growth. Anticancer Res (2011) 0.97
CNS-irrelevant T-cells enter the brain, cause blood-brain barrier disruption but no glial pathology. Eur J Neurosci (2007) 0.96
Role of the transmembrane potential in the membrane proton leak. Biophys J (2010) 0.96
Pathways leading to apoptotic neurodegeneration following trauma to the developing rat brain. Neurobiol Dis (2002) 0.95
The neural EGF family member CALEB/NGC mediates dendritic tree and spine complexity. EMBO J (2007) 0.95
Glutamate antagonists limit tumor growth. Biochem Pharmacol (2002) 0.95
Erythropoietin protects the developing brain from hyperoxia-induced cell death and proteome changes. Ann Neurol (2008) 0.94
Comparative analysis of uncoupling protein 4 distribution in various tissues under physiological conditions and during development. Biochim Biophys Acta (2009) 0.94
Interaction of inflammation and hyperoxia in a rat model of neonatal white matter damage. PLoS One (2012) 0.93
Estradiol attenuates hyperoxia-induced cell death in the developing white matter. Ann Neurol (2007) 0.93
Caspase-1-processed interleukins in hyperoxia-induced cell death in the developing brain. Ann Neurol (2005) 0.93
Transport kinetics of uncoupling proteins. Analysis of UCP1 reconstituted in planar lipid bilayers. J Biol Chem (2003) 0.92
Glutamate and its receptors in cancer. J Neural Transm (Vienna) (2014) 0.92
Polyunsaturated fatty acids activate human uncoupling proteins 1 and 2 in planar lipid bilayers. FASEB J (2007) 0.92
Dose-dependent effects of erythropoietin in propofol anesthetized neonatal rats. Brain Res (2010) 0.91
Protection with estradiol in developmental models of apoptotic neurodegeneration. Ann Neurol (2005) 0.91
Effects of repetitive exposure to pain and morphine treatment on the neonatal rat brain. Neonatology (2012) 0.91
Neuropathological sequelae of developmental exposure to antiepileptic and anesthetic drugs. Front Neurol (2012) 0.90
Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells. Cancer Biol Ther (2008) 0.90
Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment. Tumour Biol (2013) 0.89
Erythropoietin modulates autophagy signaling in the developing rat brain in an in vivo model of oxygen-toxicity. Int J Mol Sci (2012) 0.89
A new automated technique for the reconstitution of hydrophobic proteins into planar bilayer membranes. Studies of human recombinant uncoupling protein 1. Biochim Biophys Acta (2006) 0.88
Toxicity of tungsten carbide and cobalt-doped tungsten carbide nanoparticles in mammalian cells in vitro. Environ Health Perspect (2008) 0.87
Betulin elicits anti-cancer effects in tumour primary cultures and cell lines in vitro. Basic Clin Pharmacol Toxicol (2009) 0.87
A critical role for Fas/CD-95 dependent signaling pathways in the pathogenesis of hyperoxia-induced brain injury. Ann Neurol (2008) 0.87
[Effect of 17 beta-estradiol and phytoestrogen daidzein on the proliferation of pubocervical fascia and skin fibroblasts derived from women suffering from stress urinary incontinence]. Ginekol Pol (2003) 0.86
Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity. Ann Neurol (2008) 0.86
Kynurenic acid protects against the homocysteine-induced impairment of endothelial cells. Pharmacol Rep (2009) 0.86
Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line. Chem Biol Interact (2010) 0.86